Loss of Function of Intestinal IL-17 and IL-22 Producing Cells Contributes to Inflammation and Viral Persistence in SIV-Infected Rhesus Macaques

PLoS Pathogens

Volumn 12, Issue 2, 2016, Pages

  Ryan, Emily S ^a   Micci, Luca ^a   Fromentin, Rémi ^b   Paganini, Sara ^a   McGary, Colleen S ^a   Easley, Kirk ^c   Chomont, Nicolas ^b   Paiardini, Mirko ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^c EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 22; TUMOR NECROSIS FACTOR ALPHA; INTERLEUKIN DERIVATIVE; INTERLEUKIN-22;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; COLON BIOPSY; CONTROLLED STUDY; FLOW CYTOMETRY; INFLAMMATION; LOSS OF FUNCTION MUTATION; LYMPH NODE BIOPSY; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; RECTUM BIOPSY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHESUS MONKEY; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS LOAD; ANIMAL; COLON; CYTOLOGY; HUMAN; IMMUNOLOGY; LONGITUDINAL STUDY; METABOLISM; MUCOSAL IMMUNITY; RECTUM; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; TH17 CELL; VIREMIA;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; COLON; HUMANS; IMMUNITY, MUCOSAL; INFLAMMATION; INTERLEUKIN-17; INTERLEUKINS; LONGITUDINAL STUDIES; MACACA MULATTA; RECTUM; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; TH17 CELLS; VIREMIA;

EID: 84959562917     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1005412     Document Type: Article

References (60)

1. Veazey RS, DeMaria M, Chalifoux LV, Shvetz DE, Pauley DR, et al. (1998) Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection. Science280: 427–431. 9545219
2. Estes JD, Harris LD, Klatt NR, Tabb B, Pittaluga S, et al. (2010) Damaged intestinal epithelial integrity linked to microbial translocation in pathogenic simian immunodeficiency virus infections. PLoS pathogens6: e1001052. doi: 10.1371/journal.ppat.100105220808901
3. Mehandru S, Poles MA, Tenner-Racz K, Horowitz A, Hurley A, et al. (2004) Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract. The Journal of experimental medicine200: 761–770. 15365095
4. Brenchley JM, Schacker TW, Ruff LE, Price DA, Taylor JH, et al. (2004) CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. The Journal of experimental medicine200: 749–759. 15365096
5. Schmitt N, Ueno H, (2015) Regulation of human helper T cell subset differentiation by cytokines. Current opinion in immunology34: 130–136. doi: 10.1016/j.coi.2015.03.00725879814
6. Wilson CB, Rowell E, Sekimata M, (2009) Epigenetic control of T-helper-cell differentiation. Nature reviews Immunology9: 91–105. doi: 10.1038/nri248719151746
7. Korn T, Bettelli E, Oukka M, Kuchroo VK, (2009) IL-17 and Th17 Cells. Annual review of immunology27: 485–517. doi: 10.1146/annurev.immunol.021908.13271019132915
8. Bettelli E, Korn T, Kuchroo VK, (2007) Th17: the third member of the effector T cell trilogy. Current opinion in immunology19: 652–657. 17766098
9. Korn T, Oukka M, Kuchroo V, Bettelli E, (2007) Th17 cells: effector T cells with inflammatory properties. Seminars in immunology19: 362–371. 18035554
10. Chen Z, O'Shea JJ, (2008) Th17 cells: a new fate for differentiating helper T cells. Immunol Res41: 87–102. doi: 10.1007/s12026-007-8014-918172584
11. Acosta-Rodriguez EV, Rivino L, Geginat J, Jarrossay D, Gattorno M, et al. (2007) Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nature immunology8: 639–646. 17486092
12. Lee JS, Cua DJ, (2015) IL-26 AMPs up the TH17 arsenal. Nature immunology16: 897–898. doi: 10.1038/ni.325626287587
13. Meller S, Di Domizio J, Voo KS, Friedrich HC, Chamilos G, et al. (2015) TH17 cells promote microbial killing and innate immune sensing of DNA via interleukin 26. Nature immunology16: 970–979. doi: 10.1038/ni.321126168081
14. Duhen T, Geiger R, Jarrossay D, Lanzavecchia A, Sallusto F, (2009) Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells. Nature immunology10: 857–863. doi: 10.1038/ni.176719578369
15. Trifari S, Kaplan CD, Tran EH, Crellin NK, Spits H, (2009) Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)1 and T(H)2 cells. Nature immunology10: 864–871. doi: 10.1038/ni.177019578368
16. Ramirez JM, Brembilla NC, Sorg O, Chicheportiche R, Matthes T, et al. (2010) Activation of the aryl hydrocarbon receptor reveals distinct requirements for IL-22 and IL-17 production by human T helper cells. European journal of immunology40: 2450–2459. doi: 10.1002/eji.20104046120706985
17. Leung JM, Davenport M, Wolff MJ, Wiens KE, Abidi WM, et al. (2014) IL-22-producing CD4+ cells are depleted in actively inflamed colitis tissue. Mucosal immunology7: 124–133. doi: 10.1038/mi.2013.3123695510
18. Pickert G, Neufert C, Leppkes M, Zheng Y, Wittkopf N, et al. (2009) STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing. The Journal of experimental medicine206: 1465–1472. doi: 10.1084/jem.2008268319564350
19. Sugimoto K, Ogawa A, Mizoguchi E, Shimomura Y, Andoh A, et al. (2008) IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis. The Journal of clinical investigation118: 534–544. doi: 10.1172/JCI3319418172556
20. Wolk K, Kunz S, Witte E, Friedrich M, Asadullah K, et al. (2004) IL-22 increases the innate immunity of tissues. Immunity21: 241–254. 15308104
21. Zheng Y, Valdez PA, Danilenko DM, Hu Y, Sa SM, et al. (2008) Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat Med14: 282–289. doi: 10.1038/nm172018264109
22. O'Connor W, Jr.Zenewicz LA, Flavell RA, (2010) The dual nature of T(H)17 cells: shifting the focus to function. Nature immunology11: 471–476. doi: 10.1038/ni.188220485275
23. Ota N, Wong K, Valdez PA, Zheng Y, Crellin NK, et al. (2011) IL-22 bridges the lymphotoxin pathway with the maintenance of colonic lymphoid structures during infection with Citrobacter rodentium. Nature immunology12: 941–948. doi: 10.1038/ni.208921874025
24. Aujla SJ, Chan YR, Zheng M, Fei M, Askew DJ, et al. (2008) IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia. Nat Med14: 275–281. doi: 10.1038/nm171018264110
25. Kelly MN, Kolls JK, Happel K, Schwartzman JD, Schwarzenberger P, et al. (2005) Interleukin-17/interleukin-17 receptor-mediated signaling is important for generation of an optimal polymorphonuclear response against Toxoplasma gondii infection. Infection and immunity73: 617–621. 15618203
26. Huang W, Na L, Fidel PL, Schwarzenberger P, (2004) Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice. The Journal of infectious diseases190: 624–631. 15243941
27. Higgins SC, Jarnicki AG, Lavelle EC, Mills KH, (2006) TLR4 mediates vaccine-induced protective cellular immunity to Bordetella pertussis: role of IL-17-producing T cells. Journal of immunology177: 7980–7989.
28. Rudner XL, Happel KI, Young EA, Shellito JE, (2007) Interleukin-23 (IL-23)-IL-17 cytokine axis in murine Pneumocystis carinii infection. Infection and immunity75: 3055–3061. 17403873
29. Brenchley JM, Paiardini M, Knox KS, Asher AI, Cervasi B, et al. (2008) Differential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral infections. Blood112: 2826–2835. doi: 10.1182/blood-2008-05-15930118664624
30. Micci L, Cervasi B, Ende ZS, Iriele RI, Reyes-Aviles E, et al. (2012) Paucity of IL-21-producing CD4(+) T cells is associated with Th17 cell depletion in SIV infection of rhesus macaques. Blood120: 3925–3935. doi: 10.1182/blood-2012-04-42024022990011
31. Pallikkuth S, Micci L, Ende ZS, Iriele RI, Cervasi B, et al. (2013) Maintenance of intestinal Th17 cells and reduced microbial translocation in SIV-infected rhesus macaques treated with interleukin (IL)-21. PLoS pathogens9: e1003471. doi: 10.1371/journal.ppat.100347123853592
32. Cecchinato V, Trindade CJ, Laurence A, Heraud JM, Brenchley JM, et al. (2008) Altered balance between Th17 and Th1 cells at mucosal sites predicts AIDS progression in simian immunodeficiency virus-infected macaques. Mucosal immunology1: 279–288. doi: 10.1038/mi.2008.1419079189
33. Raffatellu M, Santos RL, Verhoeven DE, George MD, Wilson RP, et al. (2008) Simian immunodeficiency virus-induced mucosal interleukin-17 deficiency promotes Salmonella dissemination from the gut. Nat Med14: 421–428. doi: 10.1038/nm174318376406
34. Klatt NR, Estes JD, Sun X, Ortiz AM, Barber JS, et al. (2012) Loss of mucosal CD103+ DCs and IL-17+ and IL-22+ lymphocytes is associated with mucosal damage in SIV infection. Mucosal immunology5: 646–657. doi: 10.1038/mi.2012.3822643849
35. L. Micci, E. Ryan, C. McGary, S. Paganini, G. Silvestri, et al. (2015) IL-21 Reduces Inflammation and Virus Persistence in ART-Treated SIV-Infected Macaques. Conference on Retroviruses and Opportunistic Infections (CROI). Seattle, Washington.
36. Klatt NR, Chomont N, Douek DC, Deeks SG, (2013) Immune activation and HIV persistence: implications for curative approaches to HIV infection. Immunological reviews254: 326–342. doi: 10.1111/imr.1206523772629
37. Macal M, Sankaran S, Chun TW, Reay E, Flamm J, et al. (2008) Effective CD4+ T-cell restoration in gut-associated lymphoid tissue of HIV-infected patients is associated with enhanced Th17 cells and polyfunctional HIV-specific T-cell responses. Mucosal immunology1: 475–488. doi: 10.1038/mi.2008.3519079215
38. Brenchley JM, Paiardini M, (2011) Immunodeficiency lentiviral infections in natural and non-natural hosts. Blood118: 847–854. doi: 10.1182/blood-2010-12-32593621505193
39. Favre D, Lederer S, Kanwar B, Ma ZM, Proll S, et al. (2009) Critical loss of the balance between Th17 and T regulatory cell populations in pathogenic SIV infection. PLoS pathogens5: e1000295. doi: 10.1371/journal.ppat.100029519214220
40. Salgado M, Rallon NI, Rodes B, Lopez M, Soriano V, et al. (2011) Long-term non-progressors display a greater number of Th17 cells than HIV-infected typical progressors. Clinical immunology139: 110–114. doi: 10.1016/j.clim.2011.02.00821367666
41. Brandt L, Benfield T, Mens H, Clausen LN, Katzenstein TL, et al. (2011) Low level of regulatory T cells and maintenance of balance between regulatory T cells and TH17 cells in HIV-1-infected elite controllers. Journal of acquired immune deficiency syndromes57: 101–108. doi: 10.1097/QAI.0b013e318215a99121407087
42. Ciccone EJ, Greenwald JH, Lee PI, Biancotto A, Read SW, et al. (2011) CD4+ T cells, including Th17 and cycling subsets, are intact in the gut mucosa of HIV-1-infected long-term nonprogressors. Journal of virology85: 5880–5888. doi: 10.1128/JVI.02643-1021471231
43. Hartigan-O'Connor DJ, Abel K, Van Rompay KK, Kanwar B, McCune JM, (2012) SIV replication in the infected rhesus macaque is limited by the size of the preexisting TH17 cell compartment. Science translational medicine4: 136ra169.
44. Kim CJ, McKinnon LR, Kovacs C, Kandel G, Huibner S, et al. (2013) Mucosal Th17 cell function is altered during HIV infection and is an independent predictor of systemic immune activation. Journal of immunology191: 2164–2173.
45. Schuetz A, Deleage C, Sereti I, Rerknimitr R, Phanuphak N, et al. (2014) Initiation of ART during early acute HIV infection preserves mucosal Th17 function and reverses HIV-related immune activation. PLoS pathogens10: e1004543. doi: 10.1371/journal.ppat.100454325503054
46. Kok A, Hocqueloux L, Hocini H, Carriere M, Lefrou L, et al. (2015) Early initiation of combined antiretroviral therapy preserves immune function in the gut of HIV-infected patients. Mucosal immunology8: 127–140. doi: 10.1038/mi.2014.5024985081
47. Boniface K, Blumenschein WM, Brovont-Porth K, McGeachy MJ, Basham B, et al. (2010) Human Th17 cells comprise heterogeneous subsets including IFN-gamma-producing cells with distinct properties from the Th1 lineage. Journal of immunology185: 679–687.
48. Shi G, Cox CA, Vistica BP, Tan C, Wawrousek EF, et al. (2008) Phenotype switching by inflammation-inducing polarized Th17 cells, but not by Th1 cells. Journal of immunology181: 7205–7213.
49. Nistala K, Adams S, Cambrook H, Ursu S, Olivito B, et al. (2010) Th17 plasticity in human autoimmune arthritis is driven by the inflammatory environment. Proceedings of the National Academy of Sciences of the United States of America107: 14751–14756. doi: 10.1073/pnas.100385210720679229
50. Sandler NG, Wand H, Roque A, Law M, Nason MC, et al. (2011) Plasma levels of soluble CD14 independently predict mortality in HIV infection. The Journal of infectious diseases203: 780–790. doi: 10.1093/infdis/jiq11821252259
51. Burdo TH, Lentz MR, Autissier P, Krishnan A, Halpern E, et al. (2011) Soluble CD163 made by monocyte/macrophages is a novel marker of HIV activity in early and chronic infection prior to and after anti-retroviral therapy. The Journal of infectious diseases204: 154–163. doi: 10.1093/infdis/jir21421628670
52. Leeansyah E, Malone DF, Anthony DD, Sandberg JK, (2013) Soluble biomarkers of HIV transmission, disease progression and comorbidities. Current opinion in HIV and AIDS8: 117–124. doi: 10.1097/COH.0b013e32835c713423274365
53. Paiardini M, (2010) Th17 cells in natural SIV hosts. Current opinion in HIV and AIDS5: 166–172. doi: 10.1097/COH.0b013e328335c16120543595
54. Deeks SG, Tracy R, Douek DC, (2013) Systemic effects of inflammation on health during chronic HIV infection. Immunity39: 633–645. doi: 10.1016/j.immuni.2013.10.00124138880
55. Paiardini M, Cervasi B, Reyes-Aviles E, Micci L, Ortiz AM, et al. (2011) Low levels of SIV infection in sooty mangabey central memory CD4(+) T cells are associated with limited CCR5 expression. Nat Med17: 830–U197. doi: 10.1038/nm.239521706028
56. Micci L, Alvarez X, Iriele RI, Ortiz AM, Ryan ES, et al. (2014) CD4 Depletion in SIV-Infected Macaques Results in Macrophage and Microglia Infection with Rapid Turnover of Infected Cells. PLoS pathogens10: e1004467. doi: 10.1371/journal.ppat.100446725356757
57. Amara RR, Villinger F, Altman JD, Lydy SL, O'Neil SP, et al. (2001) Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine. Science292: 69–74. 11393868
58. Vandergeeten C, Fromentin R, Merlini E, Lawani MB, DaFonseca S, et al. (2014) Cross-clade ultrasensitive PCR-based assays to measure HIV persistence in large-cohort studies. Journal of virology88: 12385–12396. doi: 10.1128/JVI.00609-1425122785
59. Nishimura Y, Sadjadpour R, Mattapallil JJ, Igarashi T, Lee W, et al. (2009) High frequencies of resting CD4+ T cells containing integrated viral DNA are found in rhesus macaques during acute lentivirus infections. Proceedings of the National Academy of Sciences of the United States of America106: 8015–8020. doi: 10.1073/pnas.090302210619416840
60. Hansen SG, Piatak M, Jr.Ventura AB, Hughes CM, Gilbride RM, et al. (2013) Immune clearance of highly pathogenic SIV infection. Nature502: 100–104. doi: 10.1038/nature1251924025770